Angiogenic cells from human placental perfusate

Details for Australian Patent Application No. 2008305516 (hide)

Owner Celgene Cellular Therapeutics

Inventors Barrigan, Henry Rendon; Heidaran, Mohammad A.; Kang, Lin; Zhang, Xiaokui; Voskinarian-Berse, Vanessa A.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2008305516

PCT Pub. Number WO2009/042201

Priority 60/995,679 26.09.07 US

Filing date 26 September 2008

Wipo publication date 2 April 2009

International Classifications

A61K 35/20 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Milk

C12N 5/07 (2010.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Animal cells or tissues

Event Publications

6 May 2010 PCT application entered the National Phase

  PCT publication WO2009/042201 Priority application(s): WO2009/042201

12 May 2011 Alteration of Name

  The name of the applicant has been altered to Anthrogenesis Corporation

4 October 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008305539-Method for extraction and surfactant enhanced subsurface contaminant

2008305509-Dynamic instant comments